Efficacy of Oral Ibandronate in Osteoporosis

• Status: Recruiting
• Trial end date: 2025-06-08
• Target enrollment: 0
• Participant gender: All

Summary

There has been no comparative data between oral ibandronate and oral ibandronate plus active vitamin D

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shinshu University
• Treatments: Diphosphonates; Ergocalciferols; Ibandronic Acid; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Osteoporotic patients who want to take oral ibandronate

Exclusion Criteria:

• Patients who are allergic to oral ibandronate or vitamin D Patients who have not taken oral ibandronate for the last 2 years